Aldeyra Therapeutics ALDX
NASDAQ ALDX
$1.23 -0.09 (-6.82%)
At close: Sep 30, 2026 · 4:00 PM EDT

Aldeyra Therapeutics (ALDX) Notes Payables (2013 - 2014)

Updated

Aldeyra Therapeutics (ALDX) reported Notes Payables of $155,097 for Q1 2014, up 82.5% from the prior quarter.

Analysis

Aldeyra Therapeutics (ALDX) Notes Payables (2013 - 2014) Analysis & Trends

At the end of FY2013, Aldeyra Therapeutics posted Notes Payables of $85,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Aldeyra Therapeutics 74.19 Mn 74.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 155,097.00
Dec 31, 2013 85,000.00
API Access

Aldeyra Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ALDX&period=max&api_key=YOUR_API_KEY